Placement Success: Seong Chi joining Travere Therapeutics

Congratulations to Seong Chi on joining Travere Therapeutics as Director, Scientific Engagement and Professional Societies.

Seong steps into this role at a pivotal moment for Travere on the heels of FILSPARI's full FDA approval in FSGS, expanding its reach to a second rare kidney disease. Seong will help deepen the scientific dialogue and relationships with professional societies that turn a breakthrough approval into an everyday standard of care.

Proud to have partnered with Travere on this search.